Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2008-06-03
2008-06-03
Whisenant, Ethan (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100, C536S024300
Reexamination Certificate
active
07381526
ABSTRACT:
A recent discovery showed that microcompetition between a foreign polynucleotide and a cellular polynucleotide is a risk factor for some of the major chronic diseases. The invention uses this novel discovery to present assays for screening compounds based on their effectiveness in modulating such microcompetition. The effective compounds can be used in treatment of these chronic diseases. The invention also presents assays for screening compounds that can be used in treatment of chronic diseases resulting from other foreign polynucleotide-type disruptions.
REFERENCES:
patent: 5601975 (1997-02-01), Bonyhadi et al.
patent: 6060310 (2000-05-01), Cho-Chung
patent: 6310197 (2001-10-01), Rogers
Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. Jul. 1, 2000;14(13):1553-77.
Hottiger MO, Nabel GJ. Viral replication and the coactivators p300 and CBP. Trends Microbiol. Dec. 2000;8(12):560-5.
Scholer HR, Gruss P. Specific interaction between enhancer-containing molecules and cellular components. Cell. Feb. 1984;36(2):403-11.
Mercola M, Goverman J, Mirell C, Calame K. Immunoglobulin heavy-chain enhancer requires one or more tissue-specific factors. Science. Jan. 18, 1985;227(4684):266-70.
Scholer H, Haslinger A, Heguy A, Holtgreve H, Karin M. In Vivo Competition Between a Metallothionein Regulatory Element and the SV40 Enhancer. Science 1986 232: 76-80.
Cherington V, Brown M, Paucha E, St Louis J, Spiegelman BM, Roberts TM. Separation of simian virus 40 large-T-antigen-transforming and origin-binding functions from the ability to block differentiation. Mol Cell Biol. Mar. 1988;8(3):1380-4.
Adam GI, Miller SJ, Ulleras E, Franklin GC. Cell-type-specific modulation of PDGF-B regulatory elements via viral enhancer competition: a caveat for the use of reference plasmids in transient transfection assays. Gene. Oct. 31, 1996;178(1-2):25-9.
Higgins C, Chatterjee S, Cherington V. The block of adipocyte differentiation by a C-terminally truncated, but not by full-length, simian virus 40 large tumor antigen is dependent on an intact retinoblastoma susceptibility protein family binding domain. J Virol. Feb. 1996;70(2):745-52.
Awazu S, Nakata K, Hida D, Sakamoto T, Nagata K, Ishii N, Kanematsu T. Stable transfection of retinoblastoma gene promotes contact inhibition of cell growth and hepatocyte nuclear factor-1-mediated transcription in human hepatoma cells. Biochem Biophys Res Commun. Nov. 9, 1998;252(1):269-73.
Hofman K, Swinnen JV, Claessens F, Verhoeven G, Heyns W. Apparent coactivation due to interference of expression constructs with nuclear receptor expression. Mol Cell Endocrinol. Oct. 25, 2000;168(1-2):21-9.
Choi SJ, Oba Y, Gazitt Y, Alsina M, Cruz J, Anderson J, Roodman GD. Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest. Dec. 2001;108(12):1833-41.
Hu Z, Garen A. Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc Natl Acad Sci U S A. Oct. 9, 2001;98(21):12180-5.
LandOfFree
Assays for drug discovery based on microcompetition with a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assays for drug discovery based on microcompetition with a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assays for drug discovery based on microcompetition with a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2809050